Marek Trněný (Marek Trnĕný, Marek Trneny)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 18

Top Topics

Chronic Lymphocytic Leukemia

Ejection Fraction

Hematopoietic Stem Cell

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Leukemia & lymphoma

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

David J Kuter, Jiří Mayer, Merlin Efraim, Lachezar H Bogdanov, Ross Ian Baker, Zane Kaplan, Mamta Garg, Marek Trněný, Philip Young-Ill Choi, Arend Jan Gerard Jansen, Vickie McDonald, Robert J Bird, Jaromir Gumulec, Milan Košťál, Terry Gernsheimer, Waleed Ghanima, Ahmed A Daak, Nichola Cooper
Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia. Blood advances 8 (7) (2024)
Maurizio Martelli, Luca Ceriani, Giovannino Ciccone, Umberto Ricardi, Iryna Kriachok, Barbara Botto, Monica Balzarotti, Alessandra Tucci, Sara Veronica Usai, Vittorio Ruggero Zilioli, Elsa Pennese, Luca Arcaini, Anna Dabrowska-Iwanicka, Andrés José Maria Ferreri, Francesco Merli, Wei Li Zhao, Luigi Rigacci, Claudia Cellini, David C Hodgson, Codruta Ionescu, Carla Minoia, Elisa Lucchini, Michele Spina, Alexander Fosså, Andrea Janikova, Kate Cwynarski, N George Mikhaeel, Mats Jerkeman, Alice Di Rocco, Yana Stepanishyna, Umberto Vitolo, Armando Santoro, Alessandro Re, Benedetta Puccini, Jacopo Olivieri, Luigi Petrucci, Sally F Barrington, Bogdan Malkowski, Ur Metser, Annibale Versari, Stephane Chauvie, Jan Walewski, Marek Trněný, Franco Cavalli, Mary Gospodarowicz, Peter W M Johnson, Andrew John Davies, Emanuele Zucca, null null
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Philipp Berning, Mathilde Fekom, Maud Ngoya, Anthony H Goldstone, Peter Dreger, Silvia Montoto, Hervé Finel, Evgenii Shumilov, Patrice Chevallier, Didier Blaise, Tim Strüssmann, Ben Carpenter, Edouard Forcade, Cristina Castilla-Llorente, Marek Trněný, Hervé Ghesquieres, Saveria Capria, Catherine Thieblemont, Igor Wolfgang Blau, Ellen Meijer, Annoek E C Broers, Anne Huynh, Denis Caillot, Wolf Rösler, Stephanie Nguyen Quoc, Jörg Bittenbring, Arnon Nagler, Jacques-Emmanuel Galimard, Bertram Glass, Anna Sureda, Norbert Schmitz
Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years. Blood cancer journal 14 (1) (2024)
Philipp Berning, Mathilde Fekom, Maud Ngoya, Anthony H Goldstone, Peter Dreger, Silvia Montoto, Hervé Finel, Evgenii Shumilov, Patrice Chevallier, Didier Blaise, Tim Strüssmann, Ben Carpenter, Edouard Forcade, Cristina Castilla-Llorente, Marek Trněný, Hervé Ghesquieres, Saveria Capria, Catherine Thieblemont, Igor Wolfgang Blau, Ellen Meijer, Annoek E C Broers, Anne Huynh, Denis Caillot, Wolf Rösler, Stephanie Nguyen Quoc, Jörg Bittenbring, Arnon Nagler, Jacques-Emmanuel Galimard, Bertram Glass, Anna Sureda, Norbert Schmitz
Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years. Blood cancer journal 14 (1) (2024)
David J Kuter, Jiří Mayer, Merlin Efraim, Lachezar H Bogdanov, Ross Ian Baker, Zane Kaplan, Mamta Garg, Marek Trněný, Philip Young-Ill Choi, Arend Jan Gerard Jansen, Vickie McDonald, Robert J Bird, Jaromir Gumulec, Milan Košťál, Terry Gernsheimer, Waleed Ghanima, Ahmed A Daak, Nichola Cooper
Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia. Blood advances 8 (7) (2024)
David J Kuter, Jiri Mayer, Merlin Efraim, Lachezar H Bogdanov, Ross Ian Baker, Zane S Kaplan, Mamta Garg, Marek Trněný, Philip Young-Ill Choi, Arend Jan Gerard Jansen, Vickie McDonald, Robert J Bird, Jaromir Gumulec, Milan Košťál, Terry Gernsheimer, Waleed Ghanima, Ahmed Abd Almalik Daak, Nichola Cooper
Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia. Blood advances (2024)
Maurizio Martelli, Luca Ceriani, Giovannino Ciccone, Umberto Ricardi, Iryna Kriachok, Barbara Botto, Monica Balzarotti, Alessandra Tucci, Sara Veronica Usai, Vittorio Ruggero Zilioli, Elsa Pennese, Luca Arcaini, Anna Dabrowska-Iwanicka, Andrés José Maria Ferreri, Francesco Merli, Wei Li Zhao, Luigi Rigacci, Claudia Cellini, David C Hodgson, Codruta Ionescu, Carla Minoia, Elisa Lucchini, Michele Spina, Alexander Fosså, Andrea Janikova, Kate Cwynarski, N George Mikhaeel, Mats Jerkeman, Alice Di Rocco, Yana Stepanishyna, Umberto Vitolo, Armando Santoro, Alessandro Re, Benedetta Puccini, Jacopo Olivieri, Luigi Petrucci, Sally F Barrington, Bogdan Malkowski, Ur Metser, Annibale Versari, Stephane Chauvie, Jan Walewski, Marek Trněný, Franco Cavalli, Mary Gospodarowicz, Peter W M Johnson, Andrew John Davies, Emanuele Zucca, null null
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Meletios- Athanasios Dimopoulos, Stephen Samuel Opat, Shirley D'Sa, Wojciech Jurczak, Hui-Peng Lee, Gavin Cull, Roger G Owen, Paula Marlton, Björn Engelbrekt Wahlin, Miriam Santero, Helen McCarthy, Stephen P Mulligan, Alessandra Tedeschi, Jorge J Castillo, Jarosław Czyż, Carlos Fernández de Larrea, David Belada, Edward Libby, Jeffrey Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trněný, Monique C Minnema, Christian Buske, Veronique Leblond, Steven P Treon, Judith Trotman, Wai Y Chan, Jingjing Schneider, Heather Allewelt, Sheel Patel, Aileen Cohen, Constantine S Tam
Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Pier Luigi Luigi Zinzani, Jiří Mayer, Christopher R Flowers, Fontanet Bijou, Ana C Oliveira, Yuqin Song, Qingyuan Zhang, Michele Merli, Krimo Bouabdallah, Peter Ganly, Huilai Zhang, Roderick Johnson, Alejandro Martin Martin Garcia-Sancho, Mariano Provencio Pulla, Marek Trněný, Sam Yuen, Herve Tilly, Edwin Kingsley, Gayane Tumyan, Sarit E Assouline, Rebecca Auer, Elena Ivanova, Pil Kim, Sha Huang, Richard Delarue, Judith Trotman
ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Anna Waszczuk-Gajda, Olaf Penack, Giulia Sbianchi, Linda Koster, Didier Blaise, Péter Reményi, Nigel Russell, Qamar-Un-Nisa Chaudhry, Marek Trněný, Jiri Mayer, Simona Iacobelli, Guido Kobbe, Christof Scheid, Jane Apperley, Cyrille Touzeau, Stig Lenhoff, Esa Jantunen, Achilles Anagnostopoulos, Laura Paris, Paul Browne, Catherine Thieblemont, Nicolaas Schaap, Jorge Sierra, Ibrahim Yakoub Agha, Laurent Garderet, Jan Styczyński, Helene Schoemans, Ivan Moiseev, Rafael F Duarte, Zinaida Peric, Silvia Montoto, Anja van Biezen, Malgorzata Mikulska, Mahmoud Aljurf, Tapani Ruutu, Nicolaus Kröger, Curly Morris, Christian Koenecke, Stefan O Schönland, Grzegorz Władysław Basak
Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study. Journal of clinical medicine 11 (12) (2022)
Kerry Joane Savage, Steven M Horwitz, Ranjana Advani, Jacob Haaber Christensen, Eva Domingo-Domenech, Giuseppe Rossi, Judith Trotman, Onder Alpdogan, Cheolwon Suh, Kensei Tobinai, Andrei Shustov, Marek Trněný, Sam Yuen, Pier Luigi Luigi Zinzani, Lorenz Trümper, Tim Ilidge, Owen A O'Connor, Barbara Pro, Harry Miao, Veronica Bunn, Keenan Fenton, Michelle Fanale, Markus Puhlmann, Swaminathan Iyer
Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2. Blood advances 6 (19) (2022)
Radek Jakša, Jana Karolová, Michael Svatoň, Dmitry Kazantsev, Martina Grajciarová, Eva Pokorná, Zbynek Tonar, Magdalena Klánová, Lucie Winkowska, Diana Maláriková, Petra Vočková, Kristina Forsterová, Nicol Renešová, Alexandra Dolníková, Kristýna Nožičková, Pavel Dundr, Eva Froňková, Marek Trněný, Pavel Klener
Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas. Laboratory investigation; a journal of technical methods and pathology 102 (9) (2022)
Kristine Broglio, Lale Kostakoglu, Carol Ward, Federico Mattiello, Denis Sahin, Tina Nielsen, Anna McGlothlin, Corrine F Elliott, Thomas E Witzig, Laurie Helen Sehn, Marek Trněný, Umberto Vitolo, Maurizio Martelli, Margaret J Foster, Barbara A Wendelberger, Grzegorz Nowakowski, Donald A Berry
PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial design. Leukemia & lymphoma 63 (12) (2022)
Jonathan C Strefford, Malgorzata Nowicka, Chantal E Hargreaves, Cathy Burton, Andrew Davies, Rosalind Ganderton, Wolfgang Hiddemann, Chisako Iriyama, Wolfram Klapper, Kate V Latham, Maurizio Martelli, Farheen Mir, Helen Parker, Kathleen N Potter, Matthew J J Rose-Zerilli, Laurie H Sehn, Marek Trněný, Umberto Vitolo, Christopher R Bolen, Christian Klein, Andrea Knapp, Mikkel Z Oestergaard, Mark S Cragg
Single-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma. Blood advances 5 (15) (2021)
Malgorzata Nowicka, Laura K Hilton, Margaret Ashton-Key, Chantal E Hargreaves, Chern Lee, Russell Foxall, Matthew J Carter, Stephen A Beers, Kathleen N Potter, Christopher R Bolen, Christian Klein, Andrea Knapp, Farheen Mir, Matthew J J Rose-Zerilli, Cathy Burton, Wolfram Klapper, David W Scott, Laurie H Sehn, Umberto Vitolo, Maurizio Martelli, Marek Trněný, Christopher K Rushton, Graham W Slack, Pedro Farinha, Jonathan C Strefford, Mikkel Z Oestergaard, Ryan D Morin, Mark S Cragg
Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment. Blood advances 5 (15) (2021)
Vít Procházka, David Belada, Andrea Janikova, Kateřina Benešová, Heidi Mocikova, Juraj Ďuraš, Jan Pirnos, Kateřina Kopečková, Vít Campr, Tomáš Fürst, Robert Pytlik, Alice Sýkorová, Jozef Michalka, Jitka Dlouhá, Tomáš Papajík, Marek Trněný
Rituximab maintenance significantly reduces early follicular lymphoma progressions in patients treated with frontline R-CHOP. EJHaem 1 (1) (2020)
Anton W Langerak, Matthias Ritgen, Valentin Goede, Sandra Robrecht, Jasmin Bahlo, Kirsten Fischer, Michael Steurer, Marek Trněný, Stephen P Mulligan, Ulrich J M Mey, Kerstin Trunzer, Günter Fingerle-Rowson, Kathryn Humphrey, Stephan Stilgenbauer, Sebastian Böttcher, Monika Brüggemann, Michael Hallek, Michael Kneba, Jacques J M van Dongen
Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab. Blood 133 (5) (2018)
Martin Dreyling, Igor Aurer, Sergio Cortelazzo, Olivier Hermine, Georg Hess, Mats Jerkeman, Steven Le Gouill, Vincent Ribrag, Marek Trněný, Carlo Visco, Jan Walewski, Francesco Zaja, Pier Luigi Luigi Zinzani
Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations. Leukemia & lymphoma 59 (8) (2017)